Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Zongertinib is a human HER2-selective tyrosine kinase inhibitor, a novel TK that is highly selective for covalent binding to the HER2 tyrosine kinase domain (TKD).Zongertinib exhibits antitumor activity with inhibitory effects on pHER2 and EGF.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 148.00 | |
5 mg | In stock | $ 372.00 | |
10 mg | In stock | $ 497.00 | |
25 mg | In stock | $ 988.00 | |
50 mg | In stock | $ 1,570.00 | |
100 mg | In stock | $ 2,530.00 | |
500 mg | In stock | $ 4,970.00 |
Description | Zongertinib is a human HER2-selective tyrosine kinase inhibitor, a novel TK that is highly selective for covalent binding to the HER2 tyrosine kinase domain (TKD).Zongertinib exhibits antitumor activity with inhibitory effects on pHER2 and EGF. |
Synonyms | BI 764532, BI 1810631 |
Molecular Weight | 535.6 |
Formula | C29H29N9O2 |
CAS No. | 2728667-27-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 28 mg/mL (52.28 mM), Sonication and heating are recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Zongertinib 2728667-27-2 Angiogenesis JAK/STAT signaling Tyrosine Kinase/Adaptors HER Tyrosine Kinases BI1810631 BI 764532 BI-1810631 BI 1810631 BI764532 BI-764532 inhibitor inhibit